Navigation Links
NPS Pharmaceuticals Reports 2007 Financial Results
Date:3/13/2008

nt and chief executive officer of NPS, stated: "After implementing a new business plan in 2007, raising significant capital and obtaining regulatory clarity from the FDA, NPS now has the direction, the resources, and the capabilities to develop its products in specialty indications with high unmet medical needs, including short bowel syndrome and hypoparathyroidism. With a two to three year cash runway, I am confident that NPS is well-positioned to advance its pipeline and achieve commercial success."

2007 Accomplishments

During 2007, NPS reported the following accomplishments:

-- Refocused its business on specialty indications for gastrointestinal

and endocrine disorders with high unmet medical need

-- Raised more than $275.0 million through the issuance of royalty-backed

and convertible notes and the monetization of non-core assets

-- Achieved net operating cash inflow of $27.6 million for 2007 as

compared to a net operating cash outflow of $103.9 for 2006

-- Retired $191.0 million in convertible debt due in 2008

-- Completed a Phase 3 study of GATTEX(TM) (teduglutide) in short bowel

syndrome (SBS) patients who are dependent on parenteral nutrition (PN)

-- Secured an ex-North America partnership for GATTEX with Nycomed

-- Defined a clinical strategy and obtained orphan drug status for NPSP558

(parathyroid hormone 1-84 [rDNA origin injection]) as a potential

therapy for hypoparathyroidism

Francois Nader, M.D., chief executive officer-elect, stated: "We are committed to executing an ambitious clinical program in 2008. The top-line results from our Phase 3 extension study of GATTEX in patients with short bowel syndrome support our plans to initiate a confirmatory Phase 3 study of GATTEX in this indication in the third quarter of this year. We also expect to launch a pivotal trial for our PTH 1-84 compound, NPSP558, in patients with hypoparathy
'/>"/>

SOURCE NPS Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook
2. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
3. Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference
4. Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results
5. Sagent Pharmaceuticals Launches Cefazolin for Injection, USP
6. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs
8. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
9. Onyx Pharmaceuticals to Present at Cowen and Company Health Care Conference
10. Indevus Pharmaceuticals to Present at Cowen and Company 28th Annual Health Care Conference
11. VIA Pharmaceuticals to Present at Cowen and Company 28th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... report "Chocolate, Cocoa Beans, Lecithin, Sugar and Vanilla Market ... (2011 - 2016)," analyzes the chocolate market by ... market drivers, restraints, and opportunities for the chocolate market ... chocolate market is expected to grow from $83.2 billion ... CAGR of 2.7% from 2011 to 2016. , Get ...
(Date:10/18/2014)... The “Human Insulin Market- by Product Type, [Human ... Insulin (Rapid Acting, Long Acting, Premixed)], by Brand ... Forecast to 2018” provides a detailed overview of ... trends, and strategies impacting the global human insulin ... the revenue and share analysis. , The global ...
(Date:10/18/2014)... (PRWEB) October 18, 2014 The Asia-Pacific ... concerned market in Asia-Pacific with analysis and forecast of ... and is expected to reach $51,362.6 million by 2018, ... , Browse through the TOC of the Asia-Pacific hardware ... in-depth analysis provided. This also provides a glimpse of ...
(Date:10/18/2014)... 18, 2014 According to a new ... Well Type - Global Trends & Forecasts up till ... billion in 2011. This value is expected to increase ... 2017, with 10% CAGR during the same period. North ... production market in terms of hydraulic horse power supplied ...
Breaking Biology Technology:Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 2Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 3Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 4Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 2Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 3Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 4Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 5The Asia-Pacific hardware encryption display market is expected to reach $51,362.6 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific hardware encryption display market is expected to reach $51,362.6 million by 2018 - New Report by MicroMarket Monitor 3Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 2Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 3Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 4
... 9 ThermoGenesis,Corp. (Nasdaq: KOOL ), a ... and store adult stem cells, today said that ... than doubled over the same period,a year ago. ... has signed,a distribution agreement with Celling Technologies for ...
... Minn., Sept. 9 For the second consecutive,year, ... clinical study management systems, has been recognized by,Inc. ... growing private,organizations. With consistently strong growth over the ... company in the Twin Cities,metro area, and fifth ...
... LONDON, September 8, 2008 / b3c newswire ... seem to have hit the European pharmaceutical industry yet.  ... in past years, eyeforpharma’s upcoming Marketing Summit Europe, October ... biggest event of its kind ever. , ,Companies obviously ...
Cached Biology Technology:ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent 2ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent 3ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent 4ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent 5ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent 6ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent 7ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent 8ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent 9MedNet Solutions Again Recognized as one of the Fastest Growing US Companies 2Eyeforpharma's Marketing Summit is shaping up to be the biggest event of its kind ever 2
(Date:10/16/2014)... Syncytial Virus causes severe respiratory tract infections and ... year. Scientists at VIB and Ghent University have ... counteract this common virus infection. , Xavier ... that paves the way for the development of ... virus that causes suffering in numerous small children ...
(Date:10/15/2014)... 15, 2014 Sandata Technologies, LLC, an ... community-based care, today announced it released a case ... Electronic Visit Verification™ Solution (EVV™)  for Quality Care ... health company founded in 1996 and has five ... The study details the challenges facing ...
(Date:10/15/2014)... German Gauß-Allianz has admitted Johannes Gutenberg University Mainz ... Rhineland-Palatinate science hub continues to maintain a significant ... , "The acceptance of Johannes Gutenberg University ... is a milestone in the national and international ... The state of Rhineland-Palatinate can be proud that ...
Breaking Biology News(10 mins):New perspectives for development of an RSV vaccine 2Sandata Announces Case Study with Quality Care Services, Inc. 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3
... 6, 2012 Efforts to begin human clinical trials ... pigmentosa received a $37.3 million boost from the California ... of funding on Sept. 5. UC Irvine ... CIRM Disease Team Therapy Development Awards, which are designed ...
... 2012 -- After last year,s accidental discovery of "zombie"-like bees ... an elaborate experiment to learn more about the plight of ... with tiny radio trackers, and monitoring the bees, movements in ... the Hensill Hall biology building on campus. At the same ...
... Integrative Graduate Education and Research Traineeship (IGERT) program ... research and training programs for Ph.D. students at ... investigators is Thomas Cech, a University of Colorado, ... Prize in chemistry. In addition to the 123 ...
Cached Biology News:State stem cell research funding agency awards $37.3 million to aid UC Irvine efforts 2State stem cell research funding agency awards $37.3 million to aid UC Irvine efforts 3SF State biologists tag 'zombees' to track their flight 2SF State biologists tag 'zombees' to track their flight 3NSF interdisciplinary program takes on critical national research priorities 2NSF interdisciplinary program takes on critical national research priorities 3NSF interdisciplinary program takes on critical national research priorities 4NSF interdisciplinary program takes on critical national research priorities 5NSF interdisciplinary program takes on critical national research priorities 6
... Zyagen tissue microarrays are derived from Paraffin ... rigorous quality control procedures to ensure the ... manually assembled in one block, sectioned at ... on coated slides. Sections are large (3-5 ...
... from frozen embedded tissue blocks, which are ... ensure the highest quality. Tissues of each ... sectioned at a thickness of 7microns and ... (3-5mm in diameter) in comparison to core ...
... Precision-designed for Optimal Microdissection , ... enable the precise and rapid extraction of ... and cytology samples with Laser Capture Microdissection., ... for Downstream Molecular Analysis , All CapSure ...
... for Optimal Microdissection , CapSure HS and ... and rapid extraction of populations of pure ... with Laser Capture Microdissection., Ensure the ... Analysis , All CapSure LCM Caps have ...
Biology Products: